Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3.499 JPY | -0,43 % | +1,86 % | +4,48 % |
Resumen de negocios
- fabricación de productos alimentarios (81,5% de las ventas netas): productos de nutrición infantil, confitería, productos lácteos, bebidas, productos energéticos, productos congelados, etc.;
- fabricación de productos farmacéuticos (18,5%): medicamentos con receta y productos OTC.
Número de empleados: 17 290
Ventas por actividad
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Food
81,4
%
| 825 451 | 81,5 % | 864 894 | 81,4 % | +4,78 % |
Pharmaceuticals
18,6
%
| 187 641 | 18,5 % | 197 262 | 18,6 % | +5,13 % |
Ventas por región
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Japan
88,5
%
| 1 013 092 | 100,0 % | 939 725 | 88,5 % | -7,24 % |
Asia (Excluding China)
3,4
%
| 0 | 0,0 % | 35 848 | 3,4 % | - |
North America
3,0
%
| - | - | 32 000 | 3,0 % | - |
China
2,3
%
| - | - | 24 104 | 2,3 % | - |
Europe
1,4
%
| - | - | 15 250 | 1,4 % | - |
Others
1,4
%
| 0 | 0,0 % | 15 228 | 1,4 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Kazuo Kawamura
CEO | Chief Executive Officer | 70 | 01/06/12 |
Director of Finance/CFO | 69 | 01/06/15 | |
Chief Operating Officer | 66 | 28/06/18 | |
Chief Operating Officer | 69 | 01/06/14 | |
Jun Furuta
BRD | Director/Board Member | 66 | 01/06/14 |
Yuhei Matsumoto
HRO | Human Resources Officer | - | - |
Hiroyuki Tanaka
AUD | Comptroller/Controller/Auditor | 69 | 29/06/17 |
Mineo Matsuzumi
AUD | Comptroller/Controller/Auditor | 69 | 29/06/17 |
Hayato Shimada
AUD | Comptroller/Controller/Auditor | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jun Furuta
BRD | Director/Board Member | 66 | 01/06/14 |
Director/Board Member | 77 | 01/06/16 | |
Tohru Murayama
BRD | Director/Board Member | 69 | 01/06/16 |
Kazuo Kawamura
CEO | Chief Executive Officer | 70 | 01/06/12 |
Chief Operating Officer | 69 | 01/06/14 | |
Director of Finance/CFO | 69 | 01/06/15 | |
Chief Operating Officer | 66 | 28/06/18 | |
Mariko Matsumura
BRD | Director/Board Member | 64 | 28/06/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 293 459 000 | 250 866 129 ( 85,49 %) | 14 351 604 ( 4,890 %) | 85,49 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
MEIJI HOLDINGS CO LTD 4.89% | 14 350 400 | 4.89% | 321 057 481 $ |
ORIENTAL LAND CO., LTD. 0.16% | 2 875 000 | 0.16% | 92 113 218 $ |
KIKKOMAN CORPORATION 0.64% | 6 192 000 | 0.64% | 80 557 982 $ |
AUSTASIA GROUP LTD. 22.19% | 155 451 785 | 22.19% | 25 026 183 $ |
YAKULT HONSHA CO.,LTD. 0.31% | 1 062 400 | 0.31% | 21 894 513 $ |
1 209 900 | 0.24% | 19 622 049 $ | |
1 191 987 | 7.78% | 16 366 244 $ | |
TOYO SUISAN KAISHA, LTD. 0.21% | 232 000 | 0.21% | 14 524 432 $ |
1 045 220 | 0.34% | 14 499 585 $ | |
SHOEI FOODS CORPORATION 2.50% | 428 000 | 2.50% | 13 305 625 $ |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Medreich Ltd.
Medreich Ltd. Pharmaceuticals: MajorHealth Technology Medreich Ltd. manufactures and distributes pharmaceutical products. It also offers research and development, documentation services, and insights in the pharmaceutical domain. The firm is involved in manufacturing of formulations for multinationals like GlaxoSmithKline, Pfizer, Sanofi Aventis, Wyeth, Adcock Ingram, Mylan, and Actavis. The company was founded in 1976 and is headquartered in Bangalore, India. |
Pharmaceuticals: Major
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+4,48 % | 6204,04 M | |
-4,93 % | 261 mil M | |
-2,51 % | 94,98 mil M | |
+3,19 % | 46,39 mil M | |
+8,74 % | 39,99 mil M | |
-0,65 % | 39,95 mil M | |
-0,15 % | 38,02 mil M | |
-16,78 % | 30,16 mil M | |
-6,61 % | 28,72 mil M | |
+11,32 % | 24,54 mil M |
- Bolsa de valores
- Acciones
- Acción 2269
- Empresa Meiji Holdings Co Ltd